Literature DB >> 3560380

Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men.

K L Huang, F L Ruben, C R Rinaldo, L Kingsley, D W Lyter, M Ho.   

Abstract

We conducted a study to assess the effect of human immunodeficiency virus (HIV) infection on humoral immunity. Fifty-five homosexual men and 19 heterosexual men had four- to six-week postimmunization antibody responses measured to trivalent influenza vaccine and 23-valent pneumococcal vaccine. The homosexual men were divided into three groups: 20 asymptomatic HIV-seronegative men, 10 asymptomatic HIV-seropositive men, and 25 HIV-seropositive men with persistent generalized lymphadenopathy. Antibody responses to influenza antigens in the subgroups of homosexual men did not significantly differ from those of heterosexual controls. The IgG antibody responses to pneumococcal capsular types 9N and 18C in men with lymphadenopathy, and type 18C in HIV-seronegative homosexual men, were lower than those of heterosexual controls. Otherwise, responses to other ten capsular types showed no significant differences. There was no evidence of an immunosuppressive effect of vaccination on T-cell numbers, or deterioration of clinical status associated with vaccination. This study demonstrates that HIV-infected homosexual men, asymptomatic or with persistent generalized lymphadenopathy, are able to mount appropriate antibody responses to two commonly used vaccines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3560380

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  25 in total

Review 1.  AIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.

Authors:  D M Mitchell; R F Miller
Journal:  Thorax       Date:  1992-05       Impact factor: 9.139

Review 2.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 3.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

Review 4.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

Review 5.  Prevention of lung infections associated with human immunodeficiency virus infection.

Authors:  P C Hopewell
Journal:  Thorax       Date:  1989-12       Impact factor: 9.139

6.  Long-term management after splenectomy. Consider HIV infection in thrombocytopenia.

Authors:  M Fisher; B Peters; M McBride; V Kitchen
Journal:  BMJ       Date:  1994-01-08

7.  Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals.

Authors:  C A Benne; F P Kroon; M Harmsen; L Tavares; C A Kraaijeveld; J C De Jong
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

Review 8.  Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations.

Authors:  G A Bruyn; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

9.  A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.

Authors:  R T Perry; C V Plowe; B Koumaré; F Bougoudogo; K L Kotloff; G A Losonsky; S S Wasserman; M M Levine
Journal:  Bull World Health Organ       Date:  1998       Impact factor: 9.408

10.  Preventing secondary infections among HIV-positive persons.

Authors:  G A Filice; C Pomeroy
Journal:  Public Health Rep       Date:  1991 Sep-Oct       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.